Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era

References

• Akaike H. (1974). A new look at the statistical model identification. IEEE Trans Autom Control 19:716–723.
   Web of Science ®Google Scholar
• Alemán-Gómez Y. Melie-García L, Valdés-Hernández P. IBASPM: Toolbox for automatic parcellation of brain structures. In: Presented at the 12th Annual Meeting of the Organization for Human Brain Mapping. Florence, Italy: Available on CD-Rom in NeuroImage. June 11-15, 2006, Vol. 27, No.1.
   Google Scholar
• Ances BM, Roc AC, Wang J, Korczykowski M, Okawa J, Stern J, Kim J, Wolf R, Lawler K, Kolson DL, Detre JA. (2006). Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients. Neurology 66:862–866.
   Web of Science ®Google Scholar
• Aylward EH, Brettschneider PD, McArthur JC, Harris GJ, Schlaepfer TE, Henderer JD, Barta PE, Tien AY, Pearlson GD. (1995). Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry 152:987–994.
   PubMed Web of Science ®Google Scholar
• Aylward EH, Henderer JD, McArthur JC, Brettschneider PD, Harris GJ, Barta PE, Pearlson GD. (1993). Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 43:2099–2104.
   PubMed Web of Science ®Google Scholar
• Brew BJ. (2004). Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 18(Suppl 1):S75–S78.
   Google Scholar
• Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G. (2008). Neurodegeneration and Ageing in the HAART Era. J Neuroimmune Pharmacol. 4:163–174.
   Google Scholar
• Burnham K, Anderson DR. (2002). Model selection and multimodel inference: a practical-theoretic approach, 2nd ed. New York: Springer-Verlag.
   Google Scholar
• Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. (2000). Antiretroviral therapy in adults: updated recommendations of the International AIDS Society–USA Panel. JAMA 283:381–390.
   PubMed Web of Science ®Google Scholar
• Chang L, Tomasi D, Yakupov R, Lozar C, Arnold S, Caparelli E, Ernst T. (2004). Adaptation of the attention network in human immunodeficiency virus brain injury. Ann Neurol 56:259–272.
   Google Scholar
• Dore G, Correll P, Li Y, Kaldor J, Cooper D, Brew B. (1999). Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13:1249–1253.
   PubMed Web of Science ®Google Scholar
• Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, Jacobus J, Woods SP, Jernigan TL, Ellis RJ, Frank LR, Grant I. (2009). White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J NeuroVirol 15:187–195.
   PubMed Web of Science ®Google Scholar
• Heindel WC, Jernigan TL, Archibald SL, Achim CL, Masliah E, Wiley CA. (1994). The relationship of quantitative brain magnetic resonance imaging measures to neuropathologic indexes of human immunodeficiency virus infection. Arch Neurol 51:1129–1135.
   PubMedGoogle Scholar
• Jernigan TL, Archibald S, Hesselink JR, Atkinson JH, Velin RA, McCutchan JA, Chandler J, Grant I. (1993). Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group. Arch Neurol 50:250–255.
   PubMed Web of Science ®Google Scholar
• Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ. (2008). Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65:65–70.
   PubMed Web of Science ®Google Scholar
• Marder K, Albert SM, McDermott MP, McArthur JC, Schifitto G, Selnes OA, Sacktor N, Stern Y, Palumbo D, Kieburtz K, Cohen B, Orme C, Epstein LG. (2003). Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment. Neurology 60:1467–1473.
   PubMed Web of Science ®Google Scholar
• Masliah E, DeTeresa RM, Mallory ME, Hansen LA. (2000). Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 14:69–74.
   PubMed Web of Science ®Google Scholar
• McArthur JC. (2004). HIV dementia: an evolving disease. J Neuroimmunol 157:3–10.
   PubMed Web of Science ®Google Scholar
• Patel SH, Inglese M, Glosser G, Kolson DL, Grossman RI, Gonen O. (2003). Whole-brain N-acetylaspartate level and cognitive performance in HIV infection. AJNR Am J Neuroradiol 24:1587–1591.
   PubMed Web of Science ®Google Scholar
• Patel SH, Kolson DL, Glosser G, Matozzo I, Ge Y, Babb JS, Mannon LJ, Grossman RI. (2002). Correlation between percentage of brain parenchymal volume and neurocognitive performance in HIV-infected patients. AJNR Am J Neuroradiol 23:543–549.
   PubMed Web of Science ®Google Scholar
• Paul R, Cohen R, Navia B. (2002). Neuroimaging relationships to cognition in patients with HIV. Neurosci Biobehav Rev 26:353–359.
   PubMed Web of Science ®Google Scholar
• Paul RH, Ernst T, Brickman AM, Yiannoutsos CT, Tate DF, Cohen RA, Navia BA. (2008). Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV. J Int Neuropsychol Soc 14:725–733.
   Google Scholar
• Paul RH, Yiannoutsos CT, Miller EN, Chang L, Marra CM, Schifitto G, Ernst T, Singer E, Richards T, Jarvik GJ, Price R, Meyerhoff DJ, Kolson D, Ellis RJ, Gonzalez G, Lenkinski RE, Cohen RA, Navia BA. (2007). Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. J Neuropsychiatry Clin Neurosci 19:283–292.
   PubMed Web of Science ®Google Scholar
• Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L. (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. J NeuroVirol 8:136–142.
   PubMed Web of Science ®Google Scholar
• Thompson PM, Dutton RA, Hayashi KM, Toga AW, Lopez OL, Aizenstein HJ, Becker JT. (2005). Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci USA 102:15647–15652.
   PubMed Web of Science ®Google Scholar
• Thurnher MM, Schindler EG, Thurnher SA, Pernerstorfer-Schon H, Kleibl-Popov C, Rieger A. (2000). Highly active antiretroviral therapy for patients with AIDS dementia complex: effect on MR imaging findings and clinical course. AJNR Am J Neuroradiol 21:670–678.
   PubMedGoogle Scholar
• Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273–289.
   PubMed Web of Science ®Google Scholar
• Valcour V, Sacktor N. (2002). HIV-associated dementia and aging. J Ment Health Aging 8:295–306.
   Google Scholar
• Valcour V, Shikuma C, Waters M, Sacktor N. (2004). Cognitive impairment in older HIV-1 seropositive individuals: prevalence and potential mechanisms. AIDS 18(Suppl 1):S79–S86.
   Google Scholar